We are seeking investors and partners to join with us in raising capital toward the following industry solution(s):
JUNOKANA Integrated Medical Cannabis Platform
A first-of-its-kind solution for testing efficacy of medical cannabis in humans, making medical cannabis clinical use-cases measurable and providing a standardized point of reference for cannabis-based product development. JUNO Metabolomics is currently assisting customers seeking FDA approval.
• Target Fundraising: $10M